- Acasti Pharma Inc KOL Event TranscriptOct 11, 2023
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptOct 10, 2023
- Acasti Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Acasti Pharma Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q3 2023 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2023C$0.83 (-1.19%)Earnings
- Acasti Pharma Inc GTX-101 and GTX-102 Call TranscriptJan 10, 2023
- Q2 2023 Acasti Pharma Inc Earnings Call TranscriptNov 14, 2022C$0.63 (-3.08%)Earnings
- Q1 2023 Acasti Pharma Inc Earnings Call TranscriptAug 11, 2022C$1.15 (+3.60%)Earnings
- Q4 2022 Acasti Pharma Inc Earnings Call TranscriptJun 21, 2022C$1.22 (+0.83%)Earnings
- Acasti Pharma Inc Announces Positive Results for Pharmacokinetic Bridging Study Call TranscriptMay 18, 2022
- Acasti Pharma Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q3 2022 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2022C$1.58 (+4.64%)Earnings
- Q2 2022 Acasti Pharma Inc Earnings Call TranscriptNov 10, 2021C$2.06 (-1.90%)Earnings
- Acasti Pharma Inc Planned Acquisition of Grace Therapeutics Inc Call TranscriptAug 04, 2021
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptSep 30, 2020
- Q4 2020 Acasti Pharma Inc Earnings Call TranscriptJun 29, 2020C$5.28 (-13.16%)Earnings
- Q3 2020 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2020C$6.08Earnings
- Q2 2020 Acasti Pharma Inc Earnings Call TranscriptNov 13, 2019C$21.76 (-4.23%)Earnings
- Q1 2020 Acasti Pharma Inc Earnings Call TranscriptAug 14, 2019C$21.76 (+7.09%)Earnings
- Q4 2019 Acasti Pharma Inc Earnings Call TranscriptJun 26, 2019C$12.24 (+7.75%)Earnings
Acasti Pharma Inc at B Riley Neuro & Ophthalmology Conference (Virtual) Transcript
Good afternoon. This is Sahil Kazmi from the B. Riley healthcare team. And I'd like to thank everyone for being with us here today at day one of the B. Riley Virtual Neuro and Ophthalmology Conference.
I'm delighted to introduce our next presenting company, Acasti Pharma, and VP of Commercial Operations, Prashant Kohli. Prashant, thanks for joining us here today. I know it's quite an exciting time at Acasti with a lot to cover, so I'll let you take it away.
Thank you, Sahil, appreciate the opportunity, and to B. Riley as well for letting us present. Next slide, please.
Standard fair disclosure slide. This presentation contains forward-looking statements. Actual results may vary due to several risk factors. Please review our website for a detailed list of those risk factors. Next.
So at Acasti, we are a late-stage specialty drug company focused on rare and orphan diseases. Our strategy is to deploy novel drug delivery and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)